Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jul 17, 2015 (11 years ago)

0.9% Sodium Chloride Injection USP

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

0.9% Sodium Chloride Injection USP, 50 mL Single Dose VIAFLEX Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B1301, NDC 0338-0049-11.

Affected NDC 0338-0049-11

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sodium Chloride
NDC 00338-0049
9 g/1000mL Injection, Solution
Intravenous
Baxter Healthcare Corporation Rx
Recalling firm
Baxter Healthcare Corp.
NDC code
0338-0049-11
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1336-2015 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Baxter Healthcare Corp.

All 2015 recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026

Other particulate / foreign matter recalls from 2015

All particulate / foreign matter recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0719-06 D-0958-2016
Class I · High risk

0.9% Sodium Chloride Injection

Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0049-02 D-0957-2016